Novolog (Pharm-Up 1966) Ltd reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was ILS 413.06 million compared to ILS 361.39 million a year ago. Net income was ILS 11.64 million compared to ILS 11.9 million a year ago. Basic earnings per share from continuing operations was ILS 0.023 compared to ILS 0.023 a year ago. Diluted earnings per share from continuing operations was ILS 0.023 compared to ILS 0.023 a year ago.
For the six months, sales was ILS 826.26 million compared to ILS 736.76 million a year ago. Net income was ILS 1.63 million compared to ILS 23.85 million a year ago. Basic earnings per share from continuing operations was ILS 0.003 compared to ILS 0.047 a year ago. Diluted earnings per share from continuing operations was ILS 0.003 compared to ILS 0.046 a year ago.